Plain-English translation of NCT06989216 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
DermaFlow Alpha is testing a new multi-modal imaging system that uses specialized cameras to take detailed photographs of your skin. The system captures regular color images, 3D shape information, and thermal (heat) images to help doctors detect skin cancer, dermatological conditions like psoriasis and eczema, and circulation problems like Raynaud's disease and peripheral arterial disease.
Current skin screening and monitoring methods in primary care are limited. This trial exists to see whether this advanced imaging technology can more accurately detect and track skin conditions and circulation problems during routine doctor visits, potentially catching diseases earlier.
You likely qualify if…
You likely don't qualify if…
During a primary care visit, you will have full-body photographs taken from the front and back using the special camera system—a quick, painless process. You will fill out a questionnaire about any skin or circulation conditions you have or have had. Some participants may also have body measurements taken. If interested, you can return for repeat measurements once a year to track changes over time.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Sweden
Sponsor
HJN Sverige AB/Neko Health
Enrollment target
~8,000 participants
Started
February 2023
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mattias Windå, MSc
Neko Health AB
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.